Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cerebral sinus and venous thrombosis]

K M Einhäupl1, F Masuhr

  • 1Neurologische Klinik der Charité Berlin.

Therapeutische Umschau. Revue Therapeutique
|July 1, 1996
PubMed
Summary

Cerebral sinus and venous thrombosis (CSVT) are rare stroke causes, often missed due to varied symptoms. Early heparin treatment significantly reduces mortality, with anticoagulation recommended for at least three months post-diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline.

Neurological research and practice·2024
Same author

Safety of apnea testing for the diagnosis of brain death: a comprehensive study on neuromonitoring data and blood gas analysis.

European journal of neurology·2019
Same author

European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology.

European journal of neurology·2017
Same author

Outcome of heparin-treated patients with acute cerebral venous sinus thrombosis: influence of the temporal pattern of intracerebral haemorrhage.

European journal of neurology·2016
Same author

[Ancillary procedures in the diagnostics of brain death. Utilization, results and consequences in northeastern Germany].

Der Nervenarzt·2016
Same author

[Access to brain death diagnostics].

Der Nervenarzt·2014

Area of Science:

  • Neurology
  • Vascular Medicine
  • Radiology

Context:

  • Cerebral sinus and venous thrombosis (CSVT) represent less than 1% of all strokes.
  • Diagnosis is frequently delayed due to diverse clinical presentations and variable disease progression.
  • Underlying conditions are similar to those of extracerebral venous thrombosis.

Purpose:

  • To highlight the diagnostic challenges and therapeutic strategies for CSVT.
  • To emphasize the importance of early diagnosis and treatment for improving patient outcomes.

Summary:

  • CSVT diagnosis can be challenging, often overlooked due to non-specific symptoms.
  • Magnetic resonance imaging and angiography are now sufficient for diagnosis, replacing conventional angiography.
  • Full-dose heparin is the primary treatment, even with hemorrhagic infarcts, leading to <10% mortality if initiated early.
  • Post-thrombotic management includes oral anticoagulants for a minimum of three months.

Impact:

  • Early diagnosis and treatment of CSVT can significantly lower mortality rates.
  • Improved diagnostic accuracy with modern imaging techniques aids timely intervention.
  • Standardized treatment protocols, including anticoagulation, improve patient prognosis and reduce long-term complications.

Related Experiment Videos